LXR AGONIST

PROBLEM TO BE SOLVED: To provide a new LXR agonist and a medicine containing the LXR agonist as an active component and effective for the prevention and/or treatment of atherosclerosis, arteriosclerosis, etc. SOLUTION: The LXR agonist contains a compound expressed by general formula (1) (wherein R1,...

Full description

Saved in:
Bibliographic Details
Main Authors WATANABE YUICHIRO, TOSAKA AYAKO, NAKAJIMA HISASHI, MATSUDA TAKAYUKI
Format Patent
LanguageEnglish
Published 07.08.2008
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract PROBLEM TO BE SOLVED: To provide a new LXR agonist and a medicine containing the LXR agonist as an active component and effective for the prevention and/or treatment of atherosclerosis, arteriosclerosis, etc. SOLUTION: The LXR agonist contains a compound expressed by general formula (1) (wherein R1, R2and R3are each a hydrogen atom, a halogen atom, a 1-6C alkyl group, a hydroxy group or a 1-6C alkoxy group; and R4, R5and R6are each independently a hydrogen atom, a halogen atom, a 1-6C alkyl group, a hydroxy group, a 1-6C alkoxy group, an amino group, a 1-6C alkylamino group or the like), its salt or their solvate as an active component. COPYRIGHT: (C)2008,JPO&INPIT
AbstractList PROBLEM TO BE SOLVED: To provide a new LXR agonist and a medicine containing the LXR agonist as an active component and effective for the prevention and/or treatment of atherosclerosis, arteriosclerosis, etc. SOLUTION: The LXR agonist contains a compound expressed by general formula (1) (wherein R1, R2and R3are each a hydrogen atom, a halogen atom, a 1-6C alkyl group, a hydroxy group or a 1-6C alkoxy group; and R4, R5and R6are each independently a hydrogen atom, a halogen atom, a 1-6C alkyl group, a hydroxy group, a 1-6C alkoxy group, an amino group, a 1-6C alkylamino group or the like), its salt or their solvate as an active component. COPYRIGHT: (C)2008,JPO&INPIT
Author WATANABE YUICHIRO
NAKAJIMA HISASHI
MATSUDA TAKAYUKI
TOSAKA AYAKO
Author_xml – fullname: WATANABE YUICHIRO
– fullname: TOSAKA AYAKO
– fullname: NAKAJIMA HISASHI
– fullname: MATSUDA TAKAYUKI
BookMark eNrjYmDJy89L5WTg9okIUnB09_fzDA7hYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBgYWhuaWpmZGjsZEKQIAZ8oeXw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID JP2008179562A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2008179562A3
IEDL.DBID EVB
IngestDate Fri Jul 19 11:53:00 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2008179562A3
Notes Application Number: JP20070014357
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080807&DB=EPODOC&CC=JP&NR=2008179562A
ParticipantIDs epo_espacenet_JP2008179562A
PublicationCentury 2000
PublicationDate 20080807
PublicationDateYYYYMMDD 2008-08-07
PublicationDate_xml – month: 08
  year: 2008
  text: 20080807
  day: 07
PublicationDecade 2000
PublicationYear 2008
RelatedCompanies KOWA CO
RelatedCompanies_xml – name: KOWA CO
Score 2.7078984
Snippet PROBLEM TO BE SOLVED: To provide a new LXR agonist and a medicine containing the LXR agonist as an active component and effective for the prevention and/or...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title LXR AGONIST
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080807&DB=EPODOC&locale=&CC=JP&NR=2008179562A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbVISTJINjLXTU1LNNI1SUsEloOWJmm6hklJZimGRoapBmng0z79zDxCTbwiTCOYGLJhe2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGqx3DDol0VzNxcnWNcDfxd9ZzdnZ1itAzS8ILAdMe8Da3pGZgRXYjjYHZQfXMCfQtpQC5DrFTZCBLQBoXF6JEANTap4wA6cz7Oo1YQYOX-iMN5AJzXzFIgzcPhFBCo7u_n6ewSGiDEpuriHOHrpAU-Phfoj3CkBygbEYAwuwc58qwaCQaJRsmZhmZpRonAZs2KeaWhglm5gkGZkkGyWnGRqkJEoySOMxSAqvrDQDF2R1AxCZyzCwlBSVpsoCq9CSJDmw1wE9q3LQ
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbVISTJINjLXTU1LNNI1SUsEloOWJmm6hklJZimGRoapBmng0z79zDxCTbwiTCOYGLJhe2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGqx3DDol0VzNxcnWNcDfxd9ZzdnZ1itAzS8ILAdMe8Da3pGZgRXYxrYAXXfgGuYE2pZSgFynuAkysAUAjcsrEWJgSs0TZuB0hl29JszA4Qud8QYyoZmvWISB2yciSMHR3d_PMzhElEHJzTXE2UMXaGo83A_xXgFILjAWY2ABdu5TJRgUEo2SLRPTzIwSjdOADftUUwujZBOTJCOTZKPkNEODlERJBmk8BknhlZVn4PQI8fWJ9_H085Zm4IKsdAAicxkGlpKi0lRZYHVakiQHDgYAxoJ1wA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=LXR+AGONIST&rft.inventor=WATANABE+YUICHIRO&rft.inventor=TOSAKA+AYAKO&rft.inventor=NAKAJIMA+HISASHI&rft.inventor=MATSUDA+TAKAYUKI&rft.date=2008-08-07&rft.externalDBID=A&rft.externalDocID=JP2008179562A